NL-OMON47018已完成不适用
Effects of nicotinamide riboside on metabolic health in obese humans - Nicotinamide riboside and metabolic health
Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 15 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •Males and postmenopausal females
- •Aged 45-65 years at start of the study
- •Body mass index (BMI) 27 * 35 kg/m2
- •Stable dietary habits (no weight loss or gain >5kg in the past 3 months)
- •Sedentary lifestyle (not more than 2 hours of intensive exercise per week)
排除标准
- •Type 2 diabetes
- •Active diseases (cardiovascular, diabetes, liver, kidney, cancer or other)
- •Contra-indication for MRI
- •Participation in earlier research or medical examination that included PET/CT scanning
- •Alcohol consumption of >2 servings per day
- •Smoking in the past 6 months
研究者
相似试验
已完成
不适用
Nicotinamide Riboside and Metabolic HealthObesityInsulin ResistanceNCT02835664Maastricht University Medical Center15
已完成
不适用
Effects of Nicotinamide Riboside on Metabolism and Vascular FunctionAgingLipemiaNCT03501433Iowa State University16
尚未招募
Unknown
Effect of nicotinamide riboside supplementation in dilated cardiomyopathy patients to CERP, Chromadex Inc. USACTRI/2023/04/051385Chromadex Inc. USA
Enrolling By Invitation
不适用
NRM on Vascular Perfusion in Healthy AdultsVascular StiffnessNCT06345443Mayo Clinic200
撤回
2 期
Effects of Nicotinamide Riboside on the Clinical Outcome of Covid-19 in the ElderlyCOVIDNCT04407390University of Copenhagen